Search

everythinglearnresearchcommunity

for

Search:↓

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Reference values for nine hormones were established to help diagnose PCOS.

Classical PCOS types A and B are most common and linked to higher health risks.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Micronutrient supplements significantly improved PCOS symptoms in women.

Xiaozhi Yufa decoction may help treat hair loss by improving hair growth and reducing inflammation.

Men who start puberty later may have lower sperm quality and different hormone levels in adulthood.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

DHT may increase the risk of heart disease and death in elderly men.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.